125 related articles for article (PubMed ID: 24135398)
1. Decoding the pathophysiology and the genetics of multiple myeloma to identify new therapeutic targets.
Lawasut P; Groen RW; Dhimolea E; Richardson PG; Anderson KC; Mitsiades CS
Semin Oncol; 2013 Oct; 40(5):537-48. PubMed ID: 24135398
[TBL] [Abstract][Full Text] [Related]
2. Insights from the gene expression profiling of multiple myeloma.
Claudio JO; Masih-Khan E; Stewart AK
Curr Hematol Rep; 2004 Jan; 3(1):67-73. PubMed ID: 14695854
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling.
Stewart AK; Fonseca R
J Clin Oncol; 2005 Sep; 23(26):6339-44. PubMed ID: 16155017
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling and multiple myeloma.
Shaughnessy J; Zhan F; Barlogie B; Stewart AK
Best Pract Res Clin Haematol; 2005; 18(4):537-52. PubMed ID: 16026736
[TBL] [Abstract][Full Text] [Related]
6. Aberrant microRNA expression in multiple myeloma.
Dimopoulos K; Gimsing P; Grønbæk K
Eur J Haematol; 2013 Aug; 91(2):95-105. PubMed ID: 23586898
[TBL] [Abstract][Full Text] [Related]
7. [Molecular pathogenesis of myeloma for the therapeutic targets].
Hanamura I
Nihon Rinsho; 2007 Dec; 65(12):2202-8. PubMed ID: 18069261
[TBL] [Abstract][Full Text] [Related]
8. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.
Gutiérrez NC; Sarasquete ME; Misiewicz-Krzeminska I; Delgado M; De Las Rivas J; Ticona FV; Fermiñán E; Martín-Jiménez P; Chillón C; Risueño A; Hernández JM; García-Sanz R; González M; San Miguel JF
Leukemia; 2010 Mar; 24(3):629-37. PubMed ID: 20054351
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of multiple myeloma.
Tonon G
Hematol Oncol Clin North Am; 2007 Dec; 21(6):985-1006, vii. PubMed ID: 17996585
[TBL] [Abstract][Full Text] [Related]
11. Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma.
Younes H; Leleu X; Hatjiharissi E; Moreau AS; Hideshima T; Richardson P; Anderson KC; Ghobrial IM
Clin Cancer Res; 2007 Jul; 13(13):3771-5. PubMed ID: 17606706
[TBL] [Abstract][Full Text] [Related]
12. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients.
Carrasco DR; Tonon G; Huang Y; Zhang Y; Sinha R; Feng B; Stewart JP; Zhan F; Khatry D; Protopopova M; Protopopov A; Sukhdeo K; Hanamura I; Stephens O; Barlogie B; Anderson KC; Chin L; Shaughnessy JD; Brennan C; Depinho RA
Cancer Cell; 2006 Apr; 9(4):313-25. PubMed ID: 16616336
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S
Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295
[TBL] [Abstract][Full Text] [Related]
14. Deregulated microRNAs in multiple myeloma.
Benetatos L; Vartholomatos G
Cancer; 2012 Feb; 118(4):878-87. PubMed ID: 21837684
[TBL] [Abstract][Full Text] [Related]
15. Genetic heterogeneity in multiple myeloma.
Magrangeas F; Lodé L; Wuilleme S; Minvielle S; Avet-Loiseau H
Leukemia; 2005 Feb; 19(2):191-4. PubMed ID: 15538406
[TBL] [Abstract][Full Text] [Related]
16. Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines.
Verdelli D; Mattioli M; Fabris S; Nobili L; Intini D; Guerneri S; Todoerti K; Zanella A; Deliliers GL; Lombardi L; Neri A
Haematologica; 2005 Nov; 90(11):1541-8. PubMed ID: 16266902
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling defines a high-risk entity of multiple myeloma.
Zhan FH; Barlogie B; John D S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):191-203. PubMed ID: 17478923
[TBL] [Abstract][Full Text] [Related]
18. A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
Maxwell CA; Pilarski LM
Med Hypotheses; 2005; 65(5):915-21. PubMed ID: 16023302
[TBL] [Abstract][Full Text] [Related]
19. [Cytogenetic and molecular basis of multiple myeloma].
Taniwaki M; Matsumoto Y
Nihon Rinsho; 2007 Dec; 65(12):2179-86. PubMed ID: 18069258
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
